Fenwick & West advised Medigate on the deal, while Gross & Co. represented YL Ventures in this transaction. Medigate, a healthcare IoT security company, announced its acquisition...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Optimyze on the deal. Optimyze, a continuous profiling platform for infrastructure, applications and services, announced its acquisition by Elastic (NYSE: ESTC), a...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Seesaw on the deal. Seesaw, a leading SaaS-based classroom technology platform, announced a strategic investment from Providence Equity Partners. The partnership will...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Velo3D on the deal. Velo3D Inc., a leading additive manufacturing technology company for high-value metal parts, announced its public listing on the New...
You must be a Standard 1 Year member to access this content.
Fenwick advised Suplari on the deal while Perkins Coie represented Microsoft Corporation. Microsoft has acquired Suplari, a Seattle startup that uses artificial intelligence to help companies...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Dynamic Signal on the deal. Dynamic Signal announced its definitive merger agreement with SocialChorus. Both companies are leaders in the digital employee...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Vocera Communications on the deal. Vocera Communications, Inc. (NYSE:VCRA), a recognized leader in clinical communication and workflow solutions, announced it is acquiring...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Vocera Communications on the deal. Vocera Communications, Inc. (NYSE:VCRA), a recognized leader in clinical communication and workflow solutions, announced it is acquiring...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Impel NeuroPharma on the deal. Impel NeuroPharma, a late-stage pharmaceutical company developing transformative therapies for diseases of the central nervous system, announced its...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised MessageBird on the deal, and McDermott Will & Emery advised MessageBird on financing the $600 million acquisition of SparkPost. MessageBird, a...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised VELO3D Inc. on the deal. VELO3D Inc., a leader in additive manufacturing for high-value metal parts, announced its definitive business combination...
You must be a Standard 1 Year member to access this content.
